Polskie Radio reports the FDA has added a new warning to the labels of weight loss drugs, Wegovy among them. Details are at the link.
Recap by typeshit. Full story at www.polskieradio.pl.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
Online sellers pitch peptides for weight loss, anti-aging and muscle gain, and Gavin Coote's full story looks at the risks of products nobody regulates.
A surgeon on social media says the FDA has received two death reports involving black-market retatrutide. No official FDA statement is linked.
Novo Nordisk is cutting what Wegovy costs in China, Polskie Radio reports. Tap through for the size of the cut and when it takes effect.
A new 'In Discussion With' episode covers the dangers of buying unlicensed retatrutide for weight loss, a drug still in trials.
Loading…